Detalhe da pesquisa
1.
Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
Radiology
; 309(3): e231407, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051188
2.
Enhancing International Cancer Organization Collaborations: King Hussein Cancer Center and Princess Margaret Cancer Centre Model for Collaboration.
J Cancer Educ
; 37(3): 763-769, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926325
3.
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).
Int J Radiat Oncol Biol Phys
; 119(1): 100-109, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979707
4.
Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linac.
Tech Innov Patient Support Radiat Oncol
; 29: 100240, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445180
5.
Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?
Eur Urol Focus
; 9(3): 414-418, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37032280
6.
Oligometastasis in Prostate Cancer: Can We Learn from Those "Excluded" from a Phase 2 Trial?
Eur Urol Open Sci
; 52: 79-84, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284049
7.
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Eur Urol Oncol
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951820
8.
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.
Eur Urol Open Sci
; 40: 46-53, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638085
9.
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 114(4): 693-704, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031465
10.
Moving Unfavorable Small-Bowel Anatomy Away From the Prostate to Optimize Radiation Therapy Plans With the GU-Lok.
Pract Radiat Oncol
; 11(6): 510-514, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237473
11.
Implementation of Cardiac Stereotactic Radiotherapy: From Literature to the Linac.
Cureus
; 13(2): e13606, 2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33816005
12.
Mammographic Surveillance in Older Women With Breast Cancer in Canada and the United States: Are We Choosing Wisely?
Pract Radiat Oncol
; 11(4): e384-e394, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753302
13.
Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials.
Radiother Oncol
; 163: 159-164, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487764
14.
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.
Radiother Oncol
; 163: 21-31, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324914
15.
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
Eur Urol
; 80(3): 374-382, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33685838
16.
Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy.
Cancer J
; 26(1): 13-20, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977380
17.
Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience.
Cureus
; 12(9): e10618, 2020 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123432
18.
The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy.
Adv Radiat Oncol
; 5(3): 318-324, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529124
19.
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice.
Urol Oncol
; 38(11): 848.e1-848.e7, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553790
20.
[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.
BMJ Open
; 10(4): e035959, 2020 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327479